Complement proteins are integral components of amyloid plaques and cerebral
vascular amyloid ill Alzheimer brains. They can be found at the earliest s
tages of amyloid deposition and their activation coincides with the clinica
l expression of Alzheimer's dementia. This review will examine the origins
of complement in the brain and the role of P-amyloid peptide (AP) in comple
ment activation in Alzheimer's disease, an event that might serve as a nidu
s of chronic inflammation. Pharmacology therapies that may serve to inhibit
A beta-mediated complement activation will also be discussed. (C) 2000 Els
evier Science B.V. All rights reserved.